Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) Acquisitions (2019)

Updated

Oncotelic Therapeutics (OTLC) reported Acquisitions of $6,403 for Q4 2019.

Analysis

Oncotelic Therapeutics (OTLC) Acquisitions (2019) Analysis & Trends

For FY2019, Oncotelic Therapeutics posted Acquisitions of $189,286.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -17.15 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 10.59 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Oncotelic Therapeutics 5.77 Mn 4.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -6,403.00
API Access

Oncotelic Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=OTLC&period=max&api_key=YOUR_API_KEY